Fidelity Investments
GHSI

Fidelity Investments’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History

Fidelity Investments’s Portfolio GHSI Stock Details GHSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$9 – 5690
2024
Q1 		$9 Buy
+1
New +$7 ﹤0.01% 5278

Other funds holding GHSI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CPG
Cornerstone Planning Group Fairfield, New Jersey $794M AUM 22.68% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments's GHSI Position: Q2 2024 in Review

Fidelity Investments sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q2 2024, closing a stake of 1 share — an estimated $9 sold.

Fidelity Investments first reported a position in GHSI in Q1 2024 and held it in 1 quarter. The position peaked at $9 in Q1 2024. 12 funds tracked by Wall St. Rank hold GHSI as of Q2 2024.

  • Fidelity Investments reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Fidelity Investments sold 1 Guardion Health Sciences, Inc. Common Stock share in Q2 2024, an estimated $9.
  • Fidelity Investments first reported a position in Guardion Health Sciences, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
  • Fidelity Investments's Guardion Health Sciences, Inc. Common Stock position peaked at $9 in Q1 2024.
  • 12 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q2 2024.

Based on Fidelity Investments's 13F filing for Q2 2024, filed 13 Aug 2024.